INOVIO Pharmaceuticals, Inc. (INO) Plans Public Stock Offering
Alpha Vantage · TradingView · · AI-summarised by FinFlash
INOVIO Pharmaceuticals, Inc. (INO) announced its intention to conduct an underwritten public offering of common stock, with underwriters potentially having a 30-day option for up to 15% of the shares. The size and specific terms of the offering are not yet determined and its completion is contingent on market conditions.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.